CCP
JAZZ icon

Clough Capital Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History

Clough Capital Partners’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,517
Closed -$2.13M – 109
2025
Q4 		$2.13M Buy
+12,517
New +$1.92M 0.19% 69
2025
Q3 		– Sell
-12,830
Closed -$1.36M – 132
2025
Q2 		$1.36M Sell
12,830
-19,720
-61% -$2.14M 0.14% 78
2025
Q1 		$4.04M Sell
32,550
-9,900
-23% -$1.29M 0.5% 53
2024
Q4 		$5.23M Buy
+42,450
New +$5M 0.59% 54
2023
Q4 		– Sell
-3,140
Closed -$406K – 207
2023
Q3 		$406K Sell
3,140
-24,980
-89% -$3.33M 0.04% 143
2023
Q2 		$3.49M Sell
28,120
-36,290
-56% -$4.88M 0.35% 84
2023
Q1 		$9.43M Sell
64,410
-20,420
-24% -$3.02M 1.02% 32
2022
Q4 		$13.5M Buy
84,830
+12,770
+18% +$1.87M 1.37% 22
2022
Q3 		$9.61M Sell
72,060
-10,690
-13% -$1.63M 1.02% 25
2022
Q2 		$12.9M Buy
82,750
+16,340
+25% +$2.52M 1.6% 25
2022
Q1 		$10.3M Sell
66,410
-86,280
-57% -$12.5M 0.78% 50
2021
Q4 		$19.5M Buy
152,690
+34,670
+29% +$4.56M 1.3% 20
2021
Q3 		$15.4M Sell
118,020
-20,710
-15% -$3.13M 0.93% 46
2021
Q2 		$24.6M Buy
138,730
+13,950
+11% +$2.42M 1.34% 27
2021
Q1 		$20.5M Buy
+124,780
New +$20.5M 0.92% 44
2018
Q4 		– Sell
-5,100
Closed -$857K – 161
2018
Q3 		$857K Hold
5,100
– – 0.08% 98
2018
Q2 		$879K Buy
5,100
+2,100
+70% +$343K 0.08% 93
2018
Q1 		$453K Sell
3,000
-200
-6% -$29.3K 0.04% 107
2017
Q4 		$431K Sell
3,200
-2,200
-41% -$305K 0.04% 105
2017
Q3 		$790K Sell
5,400
-1,100
-17% -$166K 0.05% 90
2017
Q2 		$1.01M Sell
6,500
-17,700
-73% -$2.71M 0.07% 98
2017
Q1 		$3.51M Sell
24,200
-27,900
-54% -$3.63M 0.22% 80
2016
Q4 		$5.68M Buy
+52,100
New +$5.8M 0.38% 71
2016
Q3 		– Sell
-25,537
Closed -$3.61M – 197
2016
Q2 		$3.61M Sell
25,537
-17,794
-41% -$2.62M 0.19% 115
2016
Q1 		$5.66M Sell
43,331
-45,683
-51% -$5.69M 0.27% 101
2015
Q4 		$12.5M Buy
89,014
+48,668
+121% +$6.74M 0.59% 60
2015
Q3 		$5.36M Sell
40,346
-82,518
-67% -$14.2M 0.23% 93
2015
Q2 		$21.6M Sell
122,864
-2,000
-2% -$359K 0.83% 43
2015
Q1 		$21.6M Buy
124,864
+29,997
+32% +$5.15M 0.71% 55
2014
Q4 		$15.5M Buy
94,867
+18,676
+25% +$3.1M 0.56% 76
2014
Q3 		$12.2M Sell
76,191
-27,300
-26% -$4.2M 0.46% 75
2014
Q2 		$15.2M Buy
103,491
+62,020
+150% +$8.6M 0.48% 82
2014
Q1 		$5.75M Sell
41,471
-47,530
-53% -$7.15M 0.18% 125
2013
Q4 		$11.3M Sell
89,001
-100,700
-53% -$10.4M 0.37% 91
2013
Q3 		$17.4M Sell
189,701
-85,800
-31% -$6.92M 0.54% 80
2013
Q2 		$18.9M Buy
+275,501
New +$16.8M 0.63% 54

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Clough Capital Partners's JAZZ Position: Q1 2026 in Review

Clough Capital Partners sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2026, closing a stake of 12,517 shares — an estimated $2.13M sold.

Clough Capital Partners first reported a position in JAZZ in Q2 2013 and held it in 36 quarters. The position peaked at $24.6M in Q2 2021. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Clough Capital Partners reported no remaining Jazz Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Clough Capital Partners sold 12,517 Jazz Pharmaceuticals shares in Q1 2026, an estimated $2.13M.
  • Clough Capital Partners first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 36 quarters.
  • Clough Capital Partners's Jazz Pharmaceuticals position peaked at $24.6M in Q2 2021.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Clough Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.